» Articles » PMID: 30785638

CCL21-expression and Accumulation of CCR7 NK Cells in Livers of Patients with Primary Sclerosing Cholangitis

Abstract

The pathogenesis of primary sclerosing cholangitis (PSC), an autoimmune liver disease, remains unknown. The aim of this study was to characterize peripheral blood and intrahepatic NK cells from patients with PSC. Peripheral blood samples from patients with PSC, other autoimmune liver diseases, and from healthy control individuals were used, as well as liver tissues from PSC patients undergoing liver transplantation. Multiparameter flow cytometry showed that peripheral blood NK cells from PSC patients were significantly enriched for CCR7 and CXCR3 cells, and CCR7 but not CXCR3 cells were also significantly increased within intrahepatic NK cells. PSC patients undergoing liver transplantation furthermore had significantly higher plasma levels of the CCR7-ligand CCL21, and the CXCR3-ligands CXCL10 and CXCL11, and significantly higher levels of CCL21, but not CXCL10, were detected in liver tissues. CCR7 and CXCR3 NK cells from PSC patients exhibited significantly higher functional capacity in peripheral blood, but not liver tissues, consistent with chronic activation of these NK cells in the inflamed liver. These data show that PSC is characterized by intrahepatic CCL21 expression and accumulation of CCR7 NK cells in the inflamed liver tissue.

Citing Articles

Deconvolution analysis identified altered hepatic cell landscape in primary sclerosing cholangitis and primary biliary cholangitis.

Pham H, Pham L, Sato K Front Med (Lausanne). 2024; 11:1327973.

PMID: 38818402 PMC: 11138208. DOI: 10.3389/fmed.2024.1327973.


is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells.

Zecher B, Ellinghaus D, Schloer S, Niehrs A, Padoan B, Baumdick M Gut. 2023; 73(2):325-337.

PMID: 37788895 PMC: 10850656. DOI: 10.1136/gutjnl-2023-329524.


Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment.

Zhang N, Yao H, Zhang Z, Li Z, Chen X, Zhao Y Front Immunol. 2023; 14:1131588.

PMID: 36875101 PMC: 9978172. DOI: 10.3389/fimmu.2023.1131588.


The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56 NK cells.

Ziegler A, Fittje P, Muller L, Ahrenstorf A, Hagemann K, Hagen S Front Immunol. 2023; 14:1117320.

PMID: 36845105 PMC: 9948018. DOI: 10.3389/fimmu.2023.1117320.


Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease.

Richardson N, Wootton G, Bozward A, Oo Y Semin Immunopathol. 2022; 44(4):461-474.

PMID: 35641679 PMC: 9256571. DOI: 10.1007/s00281-022-00940-w.